Literature DB >> 30315233

Second cycle remission achievement with 7+3 and survival in adults with newly diagnosed acute myeloid leukemia: analysis of recent SWOG trials.

Megan Othus1, Elihu H Estey2,3, Guillermo Garcia-Manero4, Brent L Wood5, Derek L Stirewalt2,6, John E Godwin7, James K Weick8, Jeanne E Anderson9, Frederick R Appelbaum2,6, Harry P Erba10,11, Roland B Walter2,3,12.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30315233      PMCID： PMC6367002          DOI： 10.1038/s41375-018-0274-y

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  2 in total

1.  A randomized investigation of high-dose versus standard-dose cytosine arabinoside with daunorubicin in patients with previously untreated acute myeloid leukemia: a Southwest Oncology Group study.

Authors:  J K Weick; K J Kopecky; F R Appelbaum; D R Head; L L Kingsbury; S P Balcerzak; J N Bickers; H E Hynes; J L Welborn; S R Simon; M Grever
Journal:  Blood       Date:  1996-10-15       Impact factor: 22.113

2.  A double-blind placebo-controlled trial of granulocyte colony-stimulating factor in elderly patients with previously untreated acute myeloid leukemia: a Southwest oncology group study (9031).

Authors:  J E Godwin; K J Kopecky; D R Head; C L Willman; C P Leith; H E Hynes; S P Balcerzak; F R Appelbaum
Journal:  Blood       Date:  1998-05-15       Impact factor: 22.113
  2 in total
  3 in total

1.  Dynamic trajectory of platelet counts after the first cycle of induction chemotherapy in AML patients.

Authors:  Yazhen Bi; Zhaohui Wang; Saran Feng; Yan Wang; Yang Zhao; Hong Li; Jingyi Yu; Qian Liu; Chuansheng Zhu; Mingzhuo Li
Journal:  BMC Cancer       Date:  2022-05-01       Impact factor: 4.638

2.  Regulatory T cells promote the stemness of leukemia stem cells through IL10 cytokine-related signaling pathway.

Authors:  Yingxi Xu; Junli Mou; Ying Wang; Wei Zhou; Qing Rao; Haiyan Xing; Zheng Tian; Kejing Tang; Min Wang; Jianxiang Wang
Journal:  Leukemia       Date:  2021-08-11       Impact factor: 11.528

3.  Complete remission after the first cycle of induction chemotherapy determines the clinical efficacy of relapse-preventive immunotherapy in acute myeloid leukaemia.

Authors:  Malin S Nilsson; Alexander Hallner; Mats Brune; Staffan Nilsson; Fredrik B Thorén; Anna Martner; Kristoffer Hellstrand
Journal:  Br J Haematol       Date:  2019-12-18       Impact factor: 6.998
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.